Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Anabolic Responsiveness to Protein Intake in Advanced Cancer

NCT02793531 is registered in ClinicalTrials.gov with Texas A&M University as lead sponsor.

NCT NCT02793531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02793531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Anabolic Responsiveness to Protein Intake in Advanced Cancer
Lead sponsor
Texas A&M University
Phase
Not applicable
Overall status
Withdrawn
Start date
May 31, 2016
Completion date
May 31, 2019
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer